uroporphyrin I: RN given refers to parent cpd [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]
| ID Source | ID |
|---|---|
| PubMed CID | 72424 |
| CHEMBL ID | 429013 |
| CHEBI ID | 27484 |
| SCHEMBL ID | 4327021 |
| MeSH ID | M0105311 |
| Synonym |
|---|
| 3,8,13,18-tetrakis(carboxymethyl)-21h,23h-porphine-2,7,12,17-tetrapropanoic acid |
| 3-[(5z,10z,14z,19z)-7,12,17-tris(2-carboxyethyl)-3,8,13,18-tetrakis(carboxymethyl)-21,23-dihydroporphyrin-2-yl]propanoic acid |
| 2,7,12,17-porphinetetrapropionic acid |
| 3,8,13,18-tetrakis(carboxymethyl)porphyrin-2,7,12,17-tetrapropionic acid |
| 3,8,13,18-tetrakis(carboxymethyl)porphyrin-2,7,12,17-tetrapropanoic acid |
| CHEBI:27484 |
| C05767 |
| 607-14-7 |
| uroporphyrin i |
| CHEMBL429013 |
| SCHEMBL4327021 |
| 21h,23h-porphine-2,7,12,17-tetrapropanoic acid, 3,8,13,18-tetrakis(carboxymethyl)- |
| 7gca4yue1k , |
| unii-7gca4yue1k |
| 3,3',3'',3'''-(3,8,13,18-tetrakis-carboxymethyl-21h,23h-porphine-2,7,12,17-tetrayl)-tetrakis-propionate |
| 3,3',3'',3'''-(3,8,13,18-tetrakis-carboxymethyl-porphyrin-2,7,12,17-tetrayl)-tetra-propionic acid |
| 2,7,12,17-porphinetetrapropionate |
| 3-[7,12,17-tris-(2-carboxy-ethyl)-3,8,13,18-tetrakis-carboxymethyl-22,24-dihydro-porphin-2-yl]-propionate |
| 3,3',3'',3'''-(3,8,13,18-tetrakis-carboxymethyl-porphyrin-2,7,12,17-tetrayl)-tetra-propionate |
| 3-[7,12,17-tris-(2-carboxy-ethyl)-3,8,13,18-tetrakis-carboxymethyl-22,24-dihydro-porphin-2-yl]-propionic acid |
| 3,3',3'',3'''-(3,8,13,18-tetrakis-carboxymethyl-21h,23h-porphine-2,7,12,17-tetrayl)-tetrakis-propionic acid |
| 3,8,13,18-tetrakis(carboxymethyl)porphyrin-2,7,12,17-tetrapropanoate |
| DTXSID90896979 |
| 3,3',3'',3'''-[3,8,13,18-tetrakis(carboxymethyl)porphyrin-2,7,12,17-tetrayl]tetrapropanoic acid |
| DTXSID80862284 |
uroporphyrin i is involved in 1 pathway(s), involving a total of 0 unique proteins and 466 unique compounds
| Pathway | Proteins | Compounds |
|---|---|---|
| Biochemical pathways: part I | 0 | 466 |
| Assay ID | Title | Year | Journal | Article |
|---|---|---|---|---|
| AID106898 | Inhibition of HIV-1 P24 production. | 1994 | Journal of medicinal chemistry, Apr-15, Volume: 37, Issue:8 | Three-dimensional structure-activity analysis of a series of porphyrin derivatives with anti-HIV-1 activity targeted to the V3 loop of the gp120 envelope glycoprotein of the human immunodeficiency virus type 1. |
| AID104239 | Inhibition of HIV-1 P24 production. | 1994 | Journal of medicinal chemistry, Apr-15, Volume: 37, Issue:8 | Three-dimensional structure-activity analysis of a series of porphyrin derivatives with anti-HIV-1 activity targeted to the V3 loop of the gp120 envelope glycoprotein of the human immunodeficiency virus type 1. |
| [information is prepared from bioassay data collected from National Library of Medicine (NLM), extracted Dec-2023] | ||||
| Timeframe | Studies, This Drug (%) | All Drugs % |
|---|---|---|
| pre-1990 | 25 (44.64) | 18.7374 |
| 1990's | 15 (26.79) | 18.2507 |
| 2000's | 12 (21.43) | 29.6817 |
| 2010's | 2 (3.57) | 24.3611 |
| 2020's | 2 (3.57) | 2.80 |
| [information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023] | ||
| Publication Type | This drug (%) | All Drugs (%) |
|---|---|---|
| Trials | 0 (0.00%) | 5.53% |
| Reviews | 0 (0.00%) | 6.00% |
| Case Studies | 4 (7.02%) | 4.05% |
| Observational | 0 (0.00%) | 0.25% |
| Other | 53 (92.98%) | 84.16% |
| [information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023] | ||
| Article | Year |
|---|---|
| Antioxidant inhibition of porphyrin-induced cellular phototoxicity. Journal of photochemistry and photobiology. B, Biology, Dec-31, Volume: 65, Issue: 2-3 | 2001 |
| [information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023] | |